​

Funding Round

Series A - Baseimmune

Series A - Baseimmune

Investment Firm

Overview

Baseimmune is a biotech startup founded to create the next generation of vaccines.

Announced Date

Feb 26, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

IQ Capital

IQ Capital

IQ Capital is a early_stage_venture and seed firm.

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

5

Investor Name
Participant InvestorCreator Fund
Participant InvestorMaki.vc
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorHoxton Ventures
Participant InvestorIQ Capital

Round Details and Background

Baseimmune raised $11415554 on 2024-02-26 in Series A

Baseimmune is a biotech startup founded to create the next generation of vaccines.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 01, 2021
Seed Round - Baseimmune
4-947.6K
Nov 02, 2021
Seed Round - Baseimmune
6-4.8M
Feb 26, 2024
Series A - Baseimmune
6-11.4M

Recent Activity

There is no recent news or activity for this profile.